Here's what you need to know about Slater & Gordon Limited's $1.2 billion UK acquisition

After much speculation Australia's leading personal injury law firm, Slater & Gordon Limited (ASX:SGH), has announced it will buy Quindell PLC's Professional Services Division for $1.22 billion.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

After months of speculation, Australia's leading personal injury (PI) law firm, Slater & Gordon Limited (ASX: SGH), has announced it will acquire the Professional Services Division (PSD) of the UK firm, Quindell PLC.

The deal, worth $1,225 million, will see Slater & Gordon become the largest PI firm in the UK, jumping up from its rank at number three.

Quindell is believed to control 7% of the approximate $4.81 billion UK market.

In the past year, FTSE-listed shares of Quindell PLC have fallen over 76% as the group is subject to a probe into potentially poor accounting practices.

To fund the landmark deal for the PSD, Slater & Gordon will take on $375 million of bank debt and undertake an $890 million two-for-three pro rata accelerated renounceable entitlement offer.

That means, shareholders on the company's registry as of 7pm (Melbourne time) on Thursday 2 April 2015, will have the right to buy two new shares for every three they already hold at a price of $6.37.

Slater & Gordon shares closed at $7.55 on Friday.

The deal is subject to a majority vote from Quindell shareholders, which will be held on 17 April 2015. If successful, the deal is expected to close in May 2015.

What the deal will do for Slater & Gordon

Slater & Gordon say the deal features a number of significant benefits, including:

  • Positioning it as the UK's leading PI law firm
  • Providing channels for new business whilst complementing and extending current processes and infrastructure
  • Upside potential from a revival of the PSD business
  • 30% earnings per share accretive
  • Potentially enabling the company for entry into the S&P/ASX 100 (Index: ^AXTO) (ASX: XTO)

In an ASX announcement this morning, Slater & Gordon's Managing Director Andrew Grech said, "The acquisition is a transformational opportunity, and will allow Slater & Gordon to further penetrate the highly fragmented £2.5bn UK personal injury market… The combination of Slater & Gordon and PSD creates the number one personal injury law firm group in the UK…It further diversifies our sources of legal work, broadening access to claims management companies, insurers and insurance brokers."

Following the acquisition, Slater and Gordon is expected to have gearing of between 30% and 40%, with net debt to EBITDA (earnings before interest, tax, depreciation and amortisation) of 1.9 times.

Should you buy Slater & Gordon shares?

This is a landmark deal for Slater & Gordon and its most brazen. Whilst the firm said it has reviewed 8,000 case files whilst conducting its due diligence, a number of teething issues could result from such a large acquisition over time.

Indeed, despite Slater & Gordon confirming its 2015 financial year revenue and cash flow guidance, investors should remain cautiously optimistic about the deal.

As always, before committing to take up of your offer for new shares, it's important to maintain prudent levels of diversification within your portfolio and refrain from being heavily exposed to any one sector or company.

Owen Raskiewicz owns shares of Slater & Gordon. The Motley Fool has no position in any of the stocks mentioned. Owen welcomes your feedback on Google plus (see below) or you can follow him on Twitter @ASXinvest. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »